Stay updated with breaking news from Iontech Kurs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
24.01.2024 - Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of BioNTech SE (“BioNTech” or the “Company”) (NASDAQ: BNTX) investors concerning the Company’s ... Seite 1
18.01.2024 - Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and October 13, 2023. BioNTech is a biotechnology ...
06.11.2023 - Positive clinical data updates across multiple drug classes including antibody-drug conjugate (ADC) candidates BNT323/DB-1303, BNT325/DB-1305, CAR-T candidate BNT211, T cell therapy candidate BNT221 and mRNA cancer vaccine candidate BNT116Progress ...